CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...